Activity of venetoclax-based therapy in chronic myelomonocytic leukemia

Guillermo Montalban-Bravo; Danielle Hammond; Courtney D. DiNardo; Marina Konopleva; Gautam Borthakur; Nicholas J. Short; Jorge Ramos-Perez; Veronica Guerra; Rashmi Kanagal-Shamanna; Kiran Naqvi; Koji Sasaki; Elias Jabbour; Naveen Pemmaraju; Tapan M. Kadia; Farhad Ravandi; Naval Daver; Zeev Estrov; Sherry Pierce; Hagop Kantarjian; Guillermo Garcia-Manero

doi:10.1038/s41375-021-01240-2

Activity of venetoclax-based therapy in chronic myelomonocytic leukemia

Guillermo Montalban-Bravo, Danielle Hammond, Courtney D. DiNardo, Marina Konopleva, Gautam Borthakur, Nicholas J. Short, Jorge Ramos-Perez, Veronica Guerra, Rashmi Kanagal-Shamanna, Kiran Naqvi, Koji Sasaki, Elias Jabbour, Naveen Pemmaraju, Tapan M. Kadia, Farhad Ravandi, Naval Daver, Zeev Estrov, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Original language	English (US)
Pages (from-to)	1494-1499
Number of pages	6
Journal	Leukemia
Volume	35
Issue number	5
DOIs	https://doi.org/10.1038/s41375-021-01240-2
State	Published - May 2021

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-021-01240-2

Cite this

Montalban-Bravo, G., Hammond, D., DiNardo, C. D., Konopleva, M., Borthakur, G., Short, N. J., Ramos-Perez, J., Guerra, V., Kanagal-Shamanna, R., Naqvi, K., Sasaki, K., Jabbour, E., Pemmaraju, N., Kadia, T. M., Ravandi, F., Daver, N., Estrov, Z., Pierce, S., Kantarjian, H., & Garcia-Manero, G. (2021). Activity of venetoclax-based therapy in chronic myelomonocytic leukemia. Leukemia, 35(5), 1494-1499. https://doi.org/10.1038/s41375-021-01240-2

Montalban-Bravo, G , Hammond, D , DiNardo, CD, Konopleva, M, Borthakur, G , Short, NJ, Ramos-Perez, J, Guerra, V, Kanagal-Shamanna, R, Naqvi, K, Sasaki, K , Jabbour, E , Pemmaraju, N , Kadia, TM , Ravandi, F , Daver, N, Estrov, Z, Pierce, S, Kantarjian, H & Garcia-Manero, G 2021, 'Activity of venetoclax-based therapy in chronic myelomonocytic leukemia', Leukemia, vol. 35, no. 5, pp. 1494-1499. https://doi.org/10.1038/s41375-021-01240-2

@article{4bc58ca9701e4fd8bc691737e88120a1,

title = "Activity of venetoclax-based therapy in chronic myelomonocytic leukemia",

author = "Guillermo Montalban-Bravo and Danielle Hammond and DiNardo, {Courtney D.} and Marina Konopleva and Gautam Borthakur and Short, {Nicholas J.} and Jorge Ramos-Perez and Veronica Guerra and Rashmi Kanagal-Shamanna and Kiran Naqvi and Koji Sasaki and Elias Jabbour and Naveen Pemmaraju and Kadia, {Tapan M.} and Farhad Ravandi and Naval Daver and Zeev Estrov and Sherry Pierce and Hagop Kantarjian and Guillermo Garcia-Manero",

note = "Funding Information: Acknowledgements This work was supported in part by the University of Texas MD Anderson Cancer Center Support Grant CA016672.",

year = "2021",

month = may,

doi = "10.1038/s41375-021-01240-2",

language = "English (US)",

volume = "35",

pages = "1494--1499",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Activity of venetoclax-based therapy in chronic myelomonocytic leukemia

AU - Montalban-Bravo, Guillermo

AU - Hammond, Danielle

AU - DiNardo, Courtney D.

AU - Konopleva, Marina

AU - Borthakur, Gautam

AU - Short, Nicholas J.

AU - Ramos-Perez, Jorge

AU - Guerra, Veronica

AU - Kanagal-Shamanna, Rashmi

AU - Naqvi, Kiran

AU - Sasaki, Koji

AU - Jabbour, Elias

AU - Pemmaraju, Naveen

AU - Kadia, Tapan M.

AU - Ravandi, Farhad

AU - Daver, Naval

AU - Estrov, Zeev

AU - Pierce, Sherry

AU - Kantarjian, Hagop

AU - Garcia-Manero, Guillermo

N1 - Funding Information: Acknowledgements This work was supported in part by the University of Texas MD Anderson Cancer Center Support Grant CA016672.

PY - 2021/5

Y1 - 2021/5

UR - http://www.scopus.com/inward/record.url?scp=85104142601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85104142601&partnerID=8YFLogxK

U2 - 10.1038/s41375-021-01240-2

DO - 10.1038/s41375-021-01240-2

M3 - Article

C2 - 33846541

AN - SCOPUS:85104142601

SN - 0887-6924

VL - 35

SP - 1494

EP - 1499

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Activity of venetoclax-based therapy in chronic myelomonocytic leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this